View from the Top: Knud Vindfeldt, Head of Cultures & Enzymes, Chr. Hansen
March 2013
--- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”
DOWNLOAD ARTICLE : View from the Top: Knud Vindfeldt, Head of Cultures & Enzymes, Chr. Hansen
